New Key Statistics Module, Z-Score and F-Score
OTCPK:GNNSF Key Ratios
| Market Cap $ M | 3,281.08 |
| Enterprise Value $ M | 1,771.32 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.41 |
| Price/Sales | 3.96 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 839.00 |
| EPS (TTM) $ | -0.04 |
| Beneish M-Score | -1.23 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -6.04 |
| EV-to-EBITDA | -7.83 |
| PEG | -- |
| Shares Outstanding M | 2,128.31 |
| Net Margin (%) | -11.39 |
| Operating Margin % | -47.55 |
| Pre-tax Margin (%) | -41.84 |
| Quick Ratio | 4.65 |
| Current Ratio | 4.76 |
| ROA % (ttm) | -3.08 |
| ROE % (ttm) | -7.65 |
| ROIC % (ttm) | -32.83 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.84 |
GNNSF Number of Guru Trades
GNNSF Volume of Guru Trades
Gurus Latest Trades with OTCPK:GNNSF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:GNNSF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Genscript Biotech Corp Insider Transactions
No Available Data
News about OTCPK:GNNSF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers